Aldosterone Blockade in Chronic Kidney Disease. Influence on Arterial Stiffness and Kidney Function.

Trial Profile

Aldosterone Blockade in Chronic Kidney Disease. Influence on Arterial Stiffness and Kidney Function.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2012

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms ALBLOCK-2
  • Most Recent Events

    • 07 Feb 2012 Actual patient number (54) added as reported by ClinicalTrials.gov.
    • 07 Feb 2012 Planned end date changed from 1 Apr 2012 to 1 Feb 2012 as reported by ClinicalTrials.gov.
    • 07 Feb 2012 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top